NASDAQ: ASND

Ascendis Pharma A Stock Forecast, Predictions & Price Target

The consensus among 7 Wall Street analysts covering (NASDAQ: ASND) stock is to Strong Buy ASND stock.

Out of 7 analysts, 5 (71.43%) are recommending ASND as a Strong Buy, 1 (14.29%) are recommending ASND as a Buy, 1 (14.29%) are recommending ASND as a Hold, 0 (0%) are recommending ASND as a Sell, and 0 (0%) are recommending ASND as a Strong Sell.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

(NASDAQ: ASND) Ascendis Pharma A's forecast annual revenue growth rate of 61.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Ascendis Pharma A's revenue in 2024 is $286,793,548.On average, 6 Wall Street analysts forecast ASND's revenue for 2024 to be $25,537,619,225, with the lowest ASND revenue forecast at $23,167,228,461, and the highest ASND revenue forecast at $30,539,930,868. On average, 6 Wall Street analysts forecast ASND's revenue for 2025 to be $45,750,342,224, with the lowest ASND revenue forecast at $39,384,172,969, and the highest ASND revenue forecast at $50,781,969,246.

In 2026, ASND is forecast to generate $69,840,428,050 in revenue, with the lowest revenue forecast at $56,238,784,677 and the highest revenue forecast at $78,661,010,101.

According to 7 Wall Street analysts that have issued a 1 year ASND price target, the average ASND price target is $181.86, with the highest ASND stock price forecast at $260.00 and the lowest ASND stock price forecast at $116.00.

On average, Wall Street analysts predict that Ascendis Pharma A's share price could reach $181.86 by Apr 18, 2025. The average Ascendis Pharma A stock price prediction forecasts a potential upside of 29.08% from the current ASND share price of $140.89.

(NASDAQ: ASND) forecast ROE is N/A, which is considered weak.